在患有固体瘤和全身癌症治疗的患者中查和治疗潜伏结核病
Miguel Borregón1, David Sánchez2, Elia Martínez3
1Servicio de Oncología Médica del Hospital General Universitario de Elche, Carrer Almazara, 11, 03203, Elche, Alicante, Spain. miguelborregonrivilla@gmail.com.
概括
在癌症患者中,不一致地建议对潜在结核病 (TB) 进行查. 需要进一步的研究来评估结核病复激活风险,并指导这一群体的预防.
科学领域:
- 在瘤学瘤学.
- 传染性疾病 传染性疾病
- 免疫学 免疫学 免疫学
背景情况:
- 结核病 (TB) 是全球传染病发病率和死亡率的主要原因.
- 癌症诱导的免疫抑制增加了感染风险,结核病和癌症之间有着显著的双向发病率,通常与潜在结核病有关.
- 潜伏性结核病的重新激活是免疫受损个体的一个重大问题.
研究的目的:
- 审查潜在结核病查和癌症患者的预防建议中的差异.
- 评估目前对接受癌症治疗的患者结核病风险的理解.
- 强调需要进一步研究结核病查和预防在固体瘤患者的好处.
主要方法:
- 审查当前的医学协会指导方针和传染病建议.
- 对有关癌症患者结核病发病率的现有文献进行分析.
- 与其他风险人群相比,对实体瘤患者的结核病再激活风险的评估.
主要成果:
- 传染病和瘤学指南之间存在重大差异,涉及到潜在结核病查和预防.
- 癌症患者,特别是具有固体瘤的患者,由于寿命有限和间歇性免疫抑制,结核病复激活的风险可能较低.
- 显著缺乏前性和后性研究,专门分析潜结核病查和预防在这个患者群体中的好处.
结论:
- 固体瘤患者活跃结核病的实际规模仍有待确定.
- 进一步的研究,包括发病率研究,对于估计癌症患者的实际结核病风险至关重要.
- 需要基于证据的指导方针,用于瘤学的潜在结核病管理,以优化患者护理和减少感染风险.
更多相关视频
09:57System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
8.6K
03:47A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
222
相关概念视频
Pulmonary Tuberculosis V
179
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
179
Pulmonary Tuberculosis IV
142
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
142
Pulmonary Tuberculosis II
228
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
228
Pulmonary Tuberculosis III
325
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
325
Pulmonary Tuberculosis I
242
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
242
Tumor Immunotherapy
523
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
523
